Menu
Gibson Lab
Impact

You are here

Home > Faculty & Research > Gibson Lab > Impact
Browse by
Publications
Presentations
News Articles
Grants

Featured News

Grace's photo and quote "I am hoping this conference will provide me with the tools to confront challenges and make a true difference in my community as well as spark action on a more global scale alongside a new network of global leaders.”
Gibson Lab / Willis Lab
NEWS: 
Article
July 28, 2022
Summer Student Grace Hansen Wins Scholarship to Attend the Youth Assembly Conference in New York City
Grace Hansen, a summer undergraduate student at Burke Neurological Institute (BNI), recently won a scholarship to attend the Youth Assembly Conference in New York City in August. Grace is one of five people from the United States chosen for this scholarship.
Lab members of the Gibson Lab
Gibson Lab
NEWS: 
Press Release
July 7, 2022
Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Clinical Trial
The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild cognitive impairment (MCI).
See all news >

Publications

Gibson Lab
PUBLICATION: 
Review
Hussein N. Yassine,Wade Self,Bilal E. Kerman,Giulia Santoni,NandaKumar Navalpur Shanmugam,Laila Abdullah,Lesley R. Golden,Alfred N. Fonteh,Michael G. Harrington,Johannes Gräff,Gary E. Gibson,Raj Kalaria,Jose A. Luchsinger,Howard H. Feldman,Russell H. Swerdlow,Lance A. Johnson,Benedict C. Albensi,Berislav V. Zlokovic,Rudolph Tanzi,Stephen Cunnane,Cécilia Samieri,Nikolaos Scarmeas,Gene L. Bowman,Nutrition, Metabolism and Dementia PIA, Alzheimer's Association ISTAART
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias
Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12845. Online ahead of print.
Full Text on Wiley
Gibson Lab
PUBLICATION: 
Review
Grace E Hansen, Gary E Gibson
The α-Ketoglutarate Dehydrogenase Complex as a Hub of Plasticity in Neurodegeneration and Regeneration
Int J Mol Sci. 2022 Oct 17;23(20):12403. doi: 10.3390/ijms232012403.
Full-Text on PMC
Gibson Lab
PUBLICATION: 
Opinion Article
Gary E Gibson, Howard H Feldman, Sheng Zhang, Sarah A Flowers, José A Luchsinger
Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease
Front Med (Lausanne). 2022 Oct 4;9:1033272. doi: 10.3389/fmed.2022.1033272. eCollection 2022.
Full-Text on Frontiers
See all publications >

Grants

Gibson Lab
GRANT: 
Federal
April 15, 2016 to March 31, 2021
The Tricarboxylic Acid (Tca) Cycle in Neurodegeneration
Funding Status: 
Active Project
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Grant Number: 
P01AG014930
Investigators: 
Gary E. Gibson, Ph.D.
Project Leader
Gibson Lab
GRANT: 
Federal
September 1, 2014 to May 31, 2019
Benfotiamine in Alzheimer's Disease: A Pilot Study (Benfotiamine)
Funding Status: 
Completed Project
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Grant Number: 
R01AG043679
Investigators: 
Gary E. Gibson, Ph.D.
Principal Investigator
Pasquale Fonzetti, M.D., Ph.D.
Principal Investigator
See all grants >

Presentations

Gibson Lab
PRESENTATION: 
Poster Presentation
June 5, 2022
CHIMERYS search engine with deep mining of chimeric spectra for enhanced in-depth brain proteome in Alzheimer’s Disease
Venue: 
American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics in Minneapolis
Featured Researchers: 
Gary E. Gibson, Ph.D.
See all presentations >